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Analysis of variola virus nucleotide sequence revealed protems belonging to several families which provide the virus with the possibility of 
overcoming the barriers of specific and non-specific host defence against viral infection. The complement-bindmg proteins, lymphokine-binding 
proteins, and serine protease inhibitors can be assigned to this type, as can the proteins providing the orthopoxviruses with resistance to interferon. 
The revealed differences between the genes (proteins) of variola and vaccinia viruses under study are discussed. 
Variola virus; Complement-binding protein; Serme protease inhibitor: Lymphokine receptor 
1. INTRODUCTION 
Poxviruses are the biggest and the most complexly 
organized animal viruses. They exhibit several unique 
characteristics among which those defeating the specific 
and non-specific mechanisms of host organism defence 
[l] are particularly prominent. Investigation of molecu- 
lar genetic organization of variola virus (VAR) DNA 
yielded the intriguing information in this respect, this 
virus being the agent of the disease, smallpox, in hu- 
mans. 
In the present paper we have undertaken the analysis 
of VAR genome organization and compared it to vac- 
cinia virus (VAC). Clusters of VAR genes determining 
the modulation of various stages of complex processes 
of non-specific and specific host organism defence 
against viral infection are revealed. Comparison of 
these genes with the analogous VAC genes has been 
performed. 
2. MATERIALS AND METHODS 
VAR strain India-1967 was isolated from a patient in India in 1967. 
The strain had undergone 5 passages on chorioallantoic membranes 
(CAM) of chick embryos and are maintained in the collection of WHO 
Collaborating Center on Smallpox and Related Infections (Institute 
for Viral Preparations. Moscow, Russlan Federation). VAR culture 
was grown on CAM and after purification by sucrose density gradient 
the viral DNA was isolated by phenol deproteinization as described 
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for VAC [2]. We have set up a collection of plasmids and cosrmds with 
Insertions of various VAR DNA fragments which cover the entire 
genome of this virus 133. Sequencing of the complete coding part of 
VAR genome was performed on the basis of this collection. The 
computer analysis of poxvirus genomic organization was carried out 
as described earlier [4]. VAR sequence was compared to the published 
VAC strain Copenhagen DNA sequence [5]. 
3. RESULTS AND DISCUSSION 
Higher eukariotic organisms have mechanisms of 
specific and non-specific protection against viral infec- 
tions. Viruses, in their turn, are capable of modulating 
the reaction of the host organism which gives them the 
possibility of multiplying in an infected organism over 
some definite period of time. In the course of evolution 
different viruses developed various mechanisms of over- 
coming the protective barriers of the host. 
Inflammatory processes constitute one of the primary 
lines of host defence against viral infection. These proc- 
esses are rapidly induced to limit the spread of a virus 
during the first hours and days after the infection. At 
that time the host may not be able to realize the efficient 
cellular and humoral immune responses against the 
virus. The more efficiently a virus succeeds in the over- 
coming of these primary protective barriers of the host 
organism, the more advantages it has for multiplication 
in the infected host, at least at the early stages of the 
infection process. It should be underlined that the in- 
flammatory process is regulated by a number of media- 
tors, therefore it is difficult to overcome fully such pro- 
tective barrier and for this purpose a virus should syn- 
thesize proteins of different types. 
At present one can single out three protein families 
of the poxviruses which can modulate the development 
of the inflammatory process in response to viral infec- 
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Fig. 1. Scheme of the location of the genes coding for the complement-binding proteins (1). protein-analogs of y-interferon receptor (2) and IL-1 
receptor (3) in the genome of VAC strain Copenhagen and VAR strain India-1967. Terminal inverted repeats of viral DNAs are shaded. 
tion of an organism. These are the complement-binding 
proteins, the inhibitors of specific proteases and the 
analogs of lymphokine receptors [l]. 
The complement system is composed of more than 20 
plasma proteins. The proposed antiviral action mecha- 
nisms of complement components include virus neutral- 
ization and opsonization, lysis of virus-infected cells, 
and amplification of inflammatory and specific immune 
responses [6]. 
The presence of genes (C21L, C3L) producing the 
complement-binding proteins and inhibiting the anti- 
body-dependent complement cascade was proved for 
VAC [6,7]. Gene C21L is located in the terminal in- 
verted repeat and therefore is duplicated in the viral 
genome. The computer analysis [5] revealed two addi- 
tional VAC genes, the products of which belong to the 
family of complement-binding proteins. Our analysis 
reveals that VAR contains the same number of the 
genes belonging to this family, excluding the duplicated 
C21WB27R (Fig. 1). These data indicate, as we as- 
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Fig. 2. Scheme of the location of the ORFs coding for the proteins of serine protease inhibitor family (SPI) and the protein-analog of TNF receptor. 
See text for details. 
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Fig. 3. Comparison of the homologous regions of human TNF receptor protein (TNFr II), G4R protein of VAR (varG4R), T2 protein of Shope 
fibroma virus (sfvT2) and the analogous protein of myxoma virus (myxT2) [l 11. The conservative cysteine residues are enclosed in the rectangles. 
Dots indicate the amino acid residues identical to those of varG4R. Gaps have been introduced to maximize homology. 
sumed, that VAR has more ‘radical’ modulators of the 
host protective mechanisms provided by the proteins of 
another type, and hence, there is no need in C21L anal- 
ogous gene for VAR. 
The other class of the proteins which play the impor- 
tant role in regulation processes of complement activa- 
tion and inflammatory reactions are the proteins of 
serine protease inhibitors superfamily. In orthopox- 
viruses the first gene of this family was revealed in cow- 
pox virus [8]. Originally it was designated as 38K gene, 
then as SPI-2. Smith et al. [9] found out that VAC 
encoded a family of genes with homology to serine pro- 
tease inhibitors. Recently it was discovered [lo] that 
SPI-2 protein inhibits the processing of pro- interleukin- 
l/3 to mature form by the interleukin-l/I (IL- l/?) con- 
verting enzyme. But it is known that IL-la and IL-l/? 
together with the tumor necrosis factor-a (TNF- a) are 
the main mediators among the cytokins involved in the 
inflammatory processes. Functions of the other repre- 
sentatives of SPI family have not been clarified so far. 
It is noteworthy that the SPI gene location in VAR 
genome corresponds to that of VAC strain WR but 
differs from the location in VAC strain Copenhagen 
(Fig. 2). Strain Copenhagen gene SPI-2 is damaged, 
which can result in the decrease of viral pathogenicity. 
The SPI-1 gene is transferred from the right end to the 
left end of the genome. On the whole we can see a 
similarity between several SPI family genes in VAR and 
VAC. 
Drastic differences between these viruses were re- 
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Fig. 4. Comparison of the homologous regions of human (H) and 
mouse (M) y-interferon receptors (INGr) [13,14], B9R protein of 
VAR strain India-1967 (var) and B8R of VAC strain Copenhagen 
(cop). The designations are as in Fig. 3. 
vealed while analyzing the sequences in the right termi- 
nal region of the genome. In this region in VAR we have 
detected the G4R gene (Fig. 2) the protein product of 
which has high homology with the TNF receptor (Fig. 
3). This early viral-secreted protein is likely to bind to 
the endogenic TNF [l 11. Thus, in VAR the protein SPI- 
2 inhibits the formation of the mature form of IL-l/I, 
and the G4R gene product binds to TNF and inhibits 
the action of TNF. Activity suppression of the discussed 
main mediators of inflammatory process results in rad- 
ical inhibition of the host primary protective barrier. 
G4R-analogous genes in VAC are inactivated. 
VAR and VAC also contain the gene (B14R and 
B15R, respectively) which produces the secreted IL-l 
binding protein (Fig. 1) [12]. The other secreted protein, 
namely, B9R and B8R for VAR and VAC, respectively, 
(Fig. 1) has reliable homology with the y-interferon 
receptor (Fig. 4). 
It is known that TNF, IL-l and y-IFN are important 
regulators of cellular immunity. Antagonistic proteins 
for these regulating proteins are able to modulate their 
activity. It should be noted that VAC genes K3L and 
Table I 
Comparison of variola (VAR) and vaccinia (VAC) virus proteins 
Open reading frame Length of protein” Homology of proteinsb 
Var VAC VAR VAC 
D12L C3L 263 263 95 
PlL NIL 117 117 93 
C2L K2L 373 369 94 
C3L K3L 88 88 81 
E3L E3L 190 190 96 
B7R B5R 317 317 93 
B9R B8R 267 272 89 
B13R B13R 345 117 87 
Bl4R 222 90 
B14R B15R 149 149 96 
B25R C12L 372 353 89 
G4R B28R 349 123 62 
a Length of the proteins is presented as the number of amino acid 
residues. 
‘The homology persentage of the compared amino acid sequences is 
presented. 
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E3L encode the functions contributing to the interferon 
resistant phenotype of VAC 1151. We revealed the anal- 
ogous genes C3L and E3L for VAR (Table I). 
Thus, we can conclude that orthopoxviruses, and 
VAR in particular, have a complicated multi-factor sys- 
tem of modulation of non-specific and specific host or- 
ganism protective reactions against these viruses. The 
proteins discussed have certain differences in their 
amino acid sequence (Table I). Hence, it is necessary to 
obtain the individual proteins and study their character- 
istics in an effort to clarify their functional distinctions. 
The sequence data from this article have been depos- 
ited with the EMBL Data Library under accession um- 
ber X69198. 
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